Picture of Cosmos Pharmaceutical logo

3349 — Cosmos Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Table: Cosmos Pharmaceutical -2025/26 parent results

    Jul 13 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              May 31, 2026    May 31, 2025   May 31, 2027     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales         1.10 trln       1.01 trln                              
               (+8.7 pct)      (+4.8 pct)                              
  Operating       42.35           40.39                                
               (+4.8 pct)      (+28.3 pct)                             
  Recurring       44.62           43.16                                
               (+3.4 pct)      (+25.9 pct)                             
  Net             32.05           30.98                                
               (+3.5 pct)      (+26.7 pct)                             
  EPS          404.37 yen      390.83 yen                              
  Ann Div       82.00 yen       70.00 yen      84.00 yen               
  -Q2 Div       37.50 yen       32.50 yen      42.00 yen               
  -Q4 Div       44.50 yen       37.50 yen      42.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T
  

Recent news on Cosmos Pharmaceutical

See all news